Thus, for the detection of serum AFP, AFP-L3% and PIVKA-II, the GALAD, ASAP, GALAD-C and C-GALAD diagnostic models are preferentially recommended because they showed the highest efficacy (AUC) in the diagnosis of HCC, liver cancers (HCC + CCA), and early liver cancers. Here, AFP is linked to cholangiocarcinoma.